RYR2 and catecholaminergic polymorphic ventricular tachycardia: Limited data indicate that individuals with de novo variants of RyR2 mutation tend to experience symptoms of CPVT earlier and exhibit more severe phenotype traits compared to individuals with familial forms of CPVT [26].